AKTX vs CCL · $17.2M cap vs P/E 15, rev $12.83B
Akari Therapeutics PLC (AKTX) versus Carnival Corporation (CCL) — a side-by-side from cached financials, not a winner call.
Akari Therapeutics PLC (AKTX) is a biotechnology company listed on US.
Carnival Corporation (CCL) is a travel services company listed on US.
AKTX does not have a complete income-statement cache yet.
Latest reported CCL revenue for 2026-05-31 was $12.83B. Net income was $795.0M. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
AKTX currently screens at market cap $17.2M. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
Not investment advice. Open the AKTX and CCL stock pages for the full models.
Not investment advice.